Prism Medico Shareholders Approve Articles Change, Rs 25 Cr Share Sale

Prism Medico And Pharmacy Limited shareholders met on March 20, 2026, for an Extraordinary General Meeting (EGM). They approved two key resolutions: amendments to the company's Articles of Association (AoA) and a preferential issue of equity shares and convertible warrants.

The EGM, conducted via video conference, confirmed the company's strategy to raise fresh capital. The AoA amendments provide the necessary legal framework for these new securities. The preferential issue itself is designed to bring in funds for growth initiatives, including significant allocations for capital expenditure such as plant and machinery, civil structures, and land/building purchases over a two-year timeline.

This shareholder approval follows the board's earlier decision on February 23, 2026, to raise Rs. 25 crore through the preferential issuance of 75 lakh equity shares and 50 lakh convertible warrants at Rs. 20 each. A corrigendum was issued on March 19, 2026, to clarify minor typographical errors in the original EGM notice concerning the utilization of these funds.

With shareholder consent secured, Prism Medico can now proceed with altering Article 15 of its AoA and moving forward with the preferential allotment. This move signals a potential shift in the company's capital structure, paving the way for new investors.

However, key watchpoints remain. The successful execution and pricing of the preferential allotment are critical. Existing shareholders may face dilution due to the issuance of new shares and warrants. Investors will also monitor the company's progress in deploying the raised capital for its stated objectives within the planned two-year timeframe.

The next steps will involve finalizing the Scrutinizer's Report on the EGM voting results and communicating these results to the stock exchanges. The company will then proceed with the actual issuance and allotment of shares and warrants, including details on the specific investors.